secwatch.observer — SEC 8-K summary
======================================

Issuer:     SEELOS THERAPEUTICS, INC. (—)
CIK:        0001017491
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001099910-24-000383
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Seelos Therapeutics files for Chapter 11 bankruptcy; stock moved to OTC Pink
----------------------------------------------------------------------------

- Filed voluntary Chapter 11 petition on November 15, 2024 in Southern District of New York.
- Common stock moved from OTCQB to OTC Pink effective November 19, 2024 following bankruptcy.
- Company intends to file Form 15 to suspend SEC reporting obligations immediately.
- Securityholders warned they could experience significant or complete loss on investment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1017491/000109991024000383/0001099910-24-000383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1017491/000109991024000383/seel_8k.htm
  HTML page:      https://secwatch.observer/filing/0001099910-24-000383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer